X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (21227) 21227
Publication (1915) 1915
Book Review (1628) 1628
Newsletter (84) 84
Book Chapter (66) 66
Book / eBook (55) 55
Magazine Article (54) 54
Conference Proceeding (37) 37
Dissertation (22) 22
Newspaper Article (19) 19
Reference (11) 11
Web Resource (8) 8
Trade Publication Article (5) 5
Government Document (4) 4
Paper (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Microfilm (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (17752) 17752
humans (13760) 13760
enterobacteriaceae (7964) 7964
microbiology (7246) 7246
infectious diseases (5684) 5684
female (5220) 5220
male (5165) 5165
enterobacteriaceae infections - microbiology (4505) 4505
animals (4170) 4170
anti-bacterial agents - pharmacology (4091) 4091
microbial sensitivity tests (4032) 4032
enterobacteriaceae - isolation & purification (3700) 3700
bacteria (3520) 3520
enterobacteriaceae - drug effects (3504) 3504
escherichia-coli (3187) 3187
middle aged (3176) 3176
adult (2950) 2950
aged (2717) 2717
pharmacology & pharmacy (2706) 2706
infections (2566) 2566
enterobacteriaceae infections - drug therapy (2404) 2404
beta-lactamases - genetics (2372) 2372
klebsiella-pneumoniae (2287) 2287
anti-bacterial agents - therapeutic use (2270) 2270
prevalence (2129) 2129
epidemiology (2108) 2108
enterobacteriaceae infections - epidemiology (2034) 2034
antibiotics (2026) 2026
escherichia coli (1940) 1940
resistance (1896) 1896
immunology (1741) 1741
research (1688) 1688
enterobacteriaceae - genetics (1655) 1655
enterobacteriaceae - enzymology (1574) 1574
drug resistance (1561) 1561
beta-lactamases - metabolism (1530) 1530
genes (1525) 1525
health aspects (1494) 1494
risk factors (1477) 1477
adolescent (1436) 1436
escherichia coli - drug effects (1430) 1430
escherichia coli - isolation & purification (1430) 1430
drug resistance, bacterial (1390) 1390
infant (1380) 1380
child (1361) 1361
abridged index medicus (1322) 1322
cross infection - microbiology (1309) 1309
drug resistance in microorganisms (1307) 1307
infection (1304) 1304
bacterial proteins - genetics (1303) 1303
hospitals (1282) 1282
antimicrobial resistance (1268) 1268
analysis (1251) 1251
pathogens (1231) 1231
infant, newborn (1220) 1220
feces - microbiology (1190) 1190
plasmids (1168) 1168
child, preschool (1155) 1155
drug resistance, microbial (1150) 1150
polymerase chain reaction (1130) 1130
biochemical phenomena, metabolism, and nutrition (1113) 1113
escherichia coli - genetics (1111) 1111
aged, 80 and over (1110) 1110
gram-negative bacteria (1110) 1110
enterobacter (1102) 1102
identification (1097) 1097
e coli (1082) 1082
beta-lactamases - biosynthesis (1063) 1063
klebsiella pneumoniae - drug effects (1044) 1044
enterobacteriaceae infections - diagnosis (1039) 1039
drug resistance, multiple, bacterial (1028) 1028
bacterial infections and mycoses (1027) 1027
mice (1026) 1026
emergence (1020) 1020
escherichia coli infections - microbiology (1002) 1002
salmonella (996) 996
infectious disease (980) 980
research article (961) 961
strains (947) 947
risk-factors (943) 943
cross infection - epidemiology (938) 938
bacteremia (936) 936
klebsiella infections - microbiology (927) 927
klebsiella pneumoniae - isolation & purification (895) 895
beta lactamases (886) 886
public, environmental & occupational health (878) 878
beta-lactam resistance (876) 876
retrospective studies (872) 872
escherichia coli - enzymology (859) 859
virulence (843) 843
urinary tract infections - microbiology (837) 837
mortality (829) 829
medicine (827) 827
pseudomonas-aeruginosa (822) 822
klebsiella pneumoniae - genetics (813) 813
dna, bacterial - genetics (810) 810
esbl (807) 807
carbapenems - pharmacology (802) 802
phylogeny (802) 802
antibiotic resistance (791) 791
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (31) 31
Online Resources - Online (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (3) 3
Earth Sciences (Noranda) - Stacks (2) 2
Robarts - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (19050) 19050
French (570) 570
Spanish (427) 427
Russian (424) 424
German (373) 373
Polish (161) 161
Japanese (133) 133
Italian (108) 108
Romanian (49) 49
Turkish (45) 45
Chinese (43) 43
Portuguese (32) 32
Czech (25) 25
Korean (14) 14
Danish (13) 13
Croatian (11) 11
Dutch (11) 11
Swedish (11) 11
Hebrew (7) 7
Persian (7) 7
Ukrainian (7) 7
Norwegian (6) 6
Finnish (4) 4
Hungarian (4) 4
Bulgarian (3) 3
Serbian (3) 3
Icelandic (2) 2
Slovak (2) 2
Bosnian (1) 1
Latin (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes | Index Medicus
Journal Article
2012, Biblioteca dell'"Archivum Romanicum". Serie I, Storia, letteratura, paleografia, ISBN 8822262328, Volume 413., xxx, 51
Book
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
2008, Bologna medievale ieri e oggi, ISBN 884913102X, Volume 8, xlviii, 157
Book
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2013, Volume 34, Issue 9, pp. 940 - 946
Objective. Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge... 
Hospitalization rates | Pathogens | Databases | Original Article | Escherichia coli | Urinary tract infections | Hospitalization | Infections | Carbapenems | Klebsiella pneumoniae | Enterobacteriaceae | MORTALITY | INFECTIOUS DISEASES | SINGLE-CENTER EXPERIENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORAL-THERAPY | PYELONEPHRITIS | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ANTIBIOTIC-TREATMENT | PNEUMONIA | NOSOCOMIAL INFECTIONS | PATHOGENS | Escherichia coli Infections - drug therapy | United States - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Drug Resistance, Bacterial | Escherichia coli Infections - microbiology | Hospitalization - statistics & numerical data | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Gram-Negative Bacterial Infections - microbiology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Klebsiella Infections - epidemiology | Pseudomonas Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Index Medicus | Nursing
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 12/2010, Volume 31, Issue 12, pp. 1250 - 1256
Journal Article
2006, The Greenwood Press "Daily life through history" series, ISBN 0313332975, xii, 326
Book
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in cirrhosis are poorly known. This work was a prospective evaluation... 
PERITONITIS | LIVER-CIRRHOSIS | ACQUIRED INFECTIONS | ESCHERICHIA-COLI | ACQUISITION | RESISTANCE | HEPATORENAL-SYNDROME | SEPSIS | NORFLOXACIN PROPHYLAXIS | GASTROENTEROLOGY & HEPATOLOGY | KLEBSIELLA-PNEUMONIAE | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2013, Volume 8, Issue 7, pp. e69581 - e69581
Community-acquired urinary tract infection (CA-UTI) is the most common infection caused by extended-spectrum beta-lactamase (ESBL)-producing... 
ESCHERICHIA-COLI STRAINS | NEW-ZEALAND | (ESBL)-PRODUCING ENTEROBACTERIA | MULTIDISCIPLINARY SCIENCES | NONHOSPITALIZED PATIENTS | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | ONSET | Multivariate Analysis | Demography | Klebsiella pneumoniae - drug effects | Prevalence | Community-Acquired Infections - epidemiology | Escherichia coli - drug effects | Humans | Middle Aged | Male | beta-Lactamases - biosynthesis | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Community-Acquired Infections - drug therapy | Klebsiella pneumoniae - genetics | Female | Urinary Tract Infections - microbiology | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Klebsiella Infections - drug therapy | Drug Resistance, Microbial - drug effects | Risk Factors | Escherichia coli Infections - microbiology | Genotype | Logistic Models | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Escherichia coli - genetics | Norway - epidemiology | Klebsiella pneumoniae - enzymology | Anti-Bacterial Agents - pharmacology | Community-Acquired Infections - microbiology | Medical research | Medicine, Experimental | Urinary tract infections | Beta lactamases | Diabetes | Behavior | Health aspects | Prevalence studies (Epidemiology) | Fluoroquinolones | Laboratories | Communities | Escherichia coli | Amdinocillin | Diabetes mellitus | Fish meal | Population studies | Infections | Urinary tract | Risk analysis | Drug resistance | Epidemiology | Risk factors | Confidence intervals | Studies | Fish | Swimming | Meals | Index Medicus | Community medicine, Social medicine: 801 | Samfunnsmedisin, sosialmedisin: 801 | VDP | Basic medical, dental and veterinary science disciplines: 710 | Medical microbiology: 715 | Helsefag: 800 | Health sciences: 800 | Medisinske Fag: 700 | Medisinsk mikrobiologi: 715 | Medical disciplines: 700 | Basale medisinske, odontologiske og veterinærmedisinske fag: 710
Journal Article
Pediatric Infectious Disease Journal, ISSN 0891-3668, 04/2013, Volume 32, Issue 4, pp. e151 - e154
Background: Carbapenem-resistant Gram-negative pathogens (CRPs) are emerging as major causes of nosocomial infections that increase morbidity, mortality and... 
Carbapenem-resistant | Children | Hospital | Pediatric | Gram-negative | Nosocomial | INFECTIOUS DISEASES | nosocomial | IMMUNOLOGY | EMERGENCE | pediatric | ACINETOBACTER-BAUMANNII | IMPACT | METALLO-BETA-LACTAMASE | children | PSEUDOMONAS-AERUGINOSA | DISSEMINATION | carbapenem-resistant | PEDIATRICS | hospital | OUTBREAK | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | ENTEROBACTERIACEAE | beta-Lactam Resistance | Klebsiella Infections - pathology | Acinetobacter Infections - pathology | Humans | Cross Infection - mortality | Child, Preschool | Infant | Male | Acinetobacter Infections - mortality | Pseudomonas Infections - mortality | Acinetobacter - drug effects | Klebsiella - isolation & purification | Gram-Negative Bacterial Infections - microbiology | Cross Infection - pathology | Klebsiella Infections - epidemiology | Carbapenems - pharmacology | Pseudomonas - drug effects | Female | Child | Infant, Newborn | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Pseudomonas - isolation & purification | Klebsiella - drug effects | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Child, Hospitalized | Cross Infection - microbiology | Adolescent | Pseudomonas Infections - pathology | Survival Analysis | Gram-Negative Bacterial Infections - epidemiology | Acinetobacter - isolation & purification | Klebsiella Infections - mortality | Anti-Bacterial Agents - pharmacology | Index Medicus
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Although recommended durations of antimicrobial therapy for ventilator-associated pneumonia (VAP) range from 7 to 21 d, these are not based on prospective... 
DIAGNOSIS | ANTIBIOTIC USE | RESPIRATORY SYSTEM | PSEUDOMONAS-AERUGINOSA | INTENSIVE-CARE UNITS | NOSOCOMIAL PNEUMONIA | CRITICAL CARE MEDICINE | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring | Index Medicus | Abridged Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 252 - 257
We determined the incidence, risk factors, and outcomes of bloodstream infections (BSI) subsequent to Clostridium difficile infection (CDI). We performed a... 
CLINICAL-PRACTICE GUIDELINES | MORTALITY | AMERICA | OVERGROWTH | VANCOMYCIN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | COLONIZATION | CRITICALLY-ILL PATIENTS | EUROPEAN-SOCIETY | DISEASES SOCIETY | Coinfection | Humans | Gram-Positive Bacterial Infections - mortality | Bacteremia - mortality | Male | Enterococcus - growth & development | Clostridium Infections - microbiology | Cross Infection - pathology | Gram-Positive Bacterial Infections - microbiology | Candidiasis - pathology | Clostridium Infections - mortality | Odds Ratio | Enterobacteriaceae - growth & development | Enterobacteriaceae Infections - microbiology | Risk Factors | Bacteremia - drug therapy | Cross Infection - drug therapy | Gram-Positive Bacterial Infections - pathology | Candida - pathogenicity | Vancomycin - therapeutic use | Cross Infection - microbiology | Enterobacteriaceae - drug effects | Enterococcus - pathogenicity | Survival Analysis | Clostridium Infections - drug therapy | Enterococcus - drug effects | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - pathology | Clostridium difficile - drug effects | Enterobacteriaceae Infections - drug therapy | Multivariate Analysis | Cross Infection - mortality | Candidiasis - microbiology | Case-Control Studies | Bacteremia - microbiology | Clostridium Infections - pathology | Candidiasis - drug therapy | Metronidazole - therapeutic use | Female | Candida - growth & development | Enterobacteriaceae - pathogenicity | Enterobacteriaceae Infections - mortality | Anti-Infective Agents - therapeutic use | Candidiasis - mortality | Treatment Outcome | Enterobacteriaceae Infections - pathology | Clostridium difficile - pathogenicity | Clostridium difficile - growth & development | Aged | Candida - drug effects | Index Medicus
Journal Article